R1	AND Arg1:T1 Arg2:T2	
R2	Has_value Arg1:T4 Arg2:T3	
*	OR T5 T6
R3	Has_negation Arg1:T8 Arg2:T9	
R4	AND Arg1:T7 Arg2:T8	
R5	Has_negation Arg1:T10 Arg2:T11	
*	OR T14 T15
*	OR T12 T17
R6	Subsumes Arg1:T10 Arg2:T12	
R7	Has_value Arg1:T24 Arg2:T23	
R8	AND Arg1:T22 Arg2:T24	
R9	Has_value Arg1:T25 Arg2:T26	
R10	Has_temporal Arg1:T25 Arg2:T27	
R11	Has_value Arg1:T29 Arg2:T30	
R12	Has_temporal Arg1:T29 Arg2:T28	
*	OR T33 T32
R13	Has_qualifier Arg1:T34 Arg2:T33	
R14	Has_multiplier Arg1:T34 Arg2:T31	
R15	Has_qualifier Arg1:T37 Arg2:T38	
*	OR T36 T40 T37 T39
R16	AND Arg1:T34 Arg2:T36	
R17	Has_temporal Arg1:T34 Arg2:T41	
R18	Has_temporal Arg1:T43 Arg2:T44	
R19	Has_qualifier Arg1:T43 Arg2:T45	
R20	Has_value Arg1:T47 Arg2:T48	
*	OR T52 T53
R22	Has_temporal Arg1:T46 Arg2:T52	
R23	AND Arg1:T57 Arg2:T56	
R24	multi Arg1:T55 Arg2:T57	
R25	multi Arg1:T58 Arg2:T59	
R26	Subsumes Arg1:T55 Arg2:T58	
R27	Has_temporal Arg1:T61 Arg2:T62	
R28	multi Arg1:T63 Arg2:T64	
R29	Has_temporal Arg1:T63 Arg2:T65	
R30	Subsumes Arg1:T70 Arg2:T71	
R31	AND Arg1:T76 Arg2:T78	
R32	Subsumes Arg1:T77 Arg2:T76	
R33	multi Arg1:T80 Arg2:T81	
*	OR T66 T67 T68 T69 T70 T72 T73 T74 T75
R34	Has_multiplier Arg1:T80 Arg2:T79	
*	OR T77 T82 T80
*	OR T13 T17
*	OR T14 T17
T1	Condition 33 37	COPD
T2	Measurement 51 127	American Thoracic Society (ATS)/ European Respiratory Society (ERS) criteria
T3	Value 160 170	>=40 years
T4	Person 155 159	aged
T5	Person 130 134	Male
T6	Person 138 144	female
T7	Person 172 179	Females
T8	Condition 195 218	Child Bearing Potential
T9	Negation 191 194	Non
T10	Condition 242 265	Child Bearing Potential
T11	Negation 238 241	Non
T12	Person 283 290	Females
T13	Condition 322 341	functioning ovaries
T14	Condition 376 390	tubal ligation
T15	Condition 394 406	hysterectomy
T17	Condition 427 442	post-menopausal
T16	Person 411 418	females
T22	Condition 460 464	COPD
T23	Value 465 480	stage III or IV
T24	Measurement 494 507	GOLD criteria
T25	Measurement 540 593	Forced Expiratory Volume, measured at 1 second (FEV1)
T26	Value 594 618	<50% of predicted normal
T27	Temporal 520 539	post-bronchodilator
T28	Temporal 634 654	post- bronchodilator
T29	Measurement 655 698	FEV1/Inspiratory Vital Capacity (IVC) ratio
T30	Value 699 703	<70%
T31	Multiplier 723 733	at least 2
T32	Qualifier 746 752	severe
T33	Qualifier 734 742	moderate
T34	Condition 753 771	COPD exacerbations
T36	Drug 815 835	oral corticosteroids
T37	Drug 860 880	oral corticosteroids
T38	Qualifier 839 856	increasing dosage
T39	Drug 888 899	antibiotics
T40	Visit 903 918	hospitalization
T41	Temporal 920 958	within the 12 months preceding Visit 1
T43	Drug 973 988	COPD medication
T44	Temporal 989 1020	within 4 weeks prior to Visit 1
T45	Qualifier 966 972	stable
T46	Condition 1099 1106	smokers
T47	Measurement 1114 1129	smoking history
T48	Value 1142 1155	10 pack years
T52	Temporal 1085 1092	Current
T53	Negation 1096 1098	ex
T55	Observation 1339 1354	managed at home
T56	Visit 1347 1354	at home
T57	Procedure 1339 1346	managed
T58	Observation 1356 1367	outpatients
T59	Visit 1356 1367	outpatients
T51	Condition 1374 1384	ambulatory
T60	Observation 1389 1417	able to travel to the clinic
T61	Observation 1823 1847	written informed consent
T62	Temporal 1860 1882	prior to participation
T50	Observation 1885 1937	Able to comply with the requirements of the protocol
T63	Observation 1945 1971	available for study visits
T64	Visit 1959 1971	study visits
T65	Temporal 1972 1985	over 52 weeks
T66	Drug 1461 1476	COPD medication
T67	Drug 1492 1500	vaccines
T68	Drug 1502 1538	inhaled short-acting beta-2-agonists
T69	Drug 1550 1562	short-acting
T70	Drug 1566 1594	long-acting anticholinergics
T71	Drug 1596 1606	tiotropium
T72	Drug 1609 1633	systemic beta-2-agonists
T73	Drug 1635 1647	theophylline
T74	Drug 1649 1659	mucolytics
T75	Drug 1661 1673	antioxidants
T76	Drug 1675 1690	beta-1-agonists
T78	Condition 1696 1721	cardiovascular indication
T77	Condition 1724 1748	non-invasive ventilation
T79	Multiplier 1750 1759	long term
T80	Procedure 1760 1774	oxygen therapy
T81	Drug 1760 1766	oxygen
T82	Condition 1788 1801	Cor Pulmonale
